Literature DB >> 33123994

Purinergic Signaling Within the Tumor Microenvironment.

Dobrin Draganov1, Peter P Lee2.   

Abstract

Accumulating studies have clearly demonstrated high concentrations of extracellular ATP (eATP) within the tumor microenvironment (TME). Implications of these findings are multifold as ATP-mediated purinergic signaling has been shown to mediate a variety of cancer-related processes, including cell migration, resistance to cytotoxic therapy, and immune regulation. Broad roles of ATP within the tumor microenvironment are linked to the abundance of ATP-regulated purinergic receptors on cancer and stromal and various immune cell types, as well as on the importance of ATP release and signaling in the regulation of multiple cellular processes. ATP release and downstream purinergic signaling are emerging as a central regulator of tumor growth and an important target for therapeutic intervention. In this chapter, we summarize the major roles of purinergic signaling in the tumor microenvironment with a specific focus on its critical roles in the induction of immunogenic cancer cell death and immune modulation.

Entities:  

Keywords:  Autophagy; Cancer immunotherapy; Extracellular ATP (eATP); Immunogenic cell death (ICD); P2X/P2Y receptors; Purinergic signaling; Tumor microenvironment (TME)

Mesh:

Substances:

Year:  2021        PMID: 33123994     DOI: 10.1007/978-3-030-47189-7_5

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  3 in total

1.  [Interference of P2X4 receptor expression in tumor-associated macrophages suppresses migration and invasion of glioma cells].

Authors:  X Yang; H Shen; Q Li; Z Dai; R Yang; G Huang; R Chen; F Wang; J Song; H Hua
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-05-20

2.  The Tyrosine Phosphatase hPTPRβ Controls the Early Signals and Dopaminergic Cells Viability via the P2X7 Receptor.

Authors:  Francisco Llavero Bernal; Miriam Luque Montoro; Alazne Arrazola Sastre; Hadriano M Lacerda; José Luis Zugaza
Journal:  Int J Mol Sci       Date:  2021-11-29       Impact factor: 5.923

Review 3.  Adenosine signaling: Optimal target for gastric cancer immunotherapy.

Authors:  Junqing Wang; Linyong Du; Xiangjian Chen
Journal:  Front Immunol       Date:  2022-09-16       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.